Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022		145,013,786
Beginning balance at Dec. 31, 2022	$ 339,310	$ 1	$ 951,946	$ (233)	$ (612,404)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	54,263		54,263
Exercise of stock options (in shares)		1,362,403
Exercise of stock options	4,777		4,777
Vesting of restricted stock units (in shares)		2,844,246
Vesting of restricted stock units	108		108
Issuance of common stock under employee stock purchase plan (in shares)		625,111
Issuance of common stock under employee stock purchase plan	4,757		4,757
Other comprehensive income (loss)	185			185
Net loss	(70,279)				(70,279)
Ending balance (in shares) at Jun. 30, 2023		149,845,546
Ending balance at Jun. 30, 2023	333,121	$ 1	1,015,851	(48)	(682,683)
Beginning balance (in shares) at Mar. 31, 2023		146,627,024
Beginning balance at Mar. 31, 2023	325,085	$ 1	982,128	(96)	(656,948)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	25,530		25,530
Exercise of stock options (in shares)		1,006,887
Exercise of stock options	3,328		3,328
Vesting of restricted stock units (in shares)		1,586,524
Vesting of restricted stock units	108		108
Issuance of common stock under employee stock purchase plan (in shares)		625,111
Issuance of common stock under employee stock purchase plan	4,757		4,757
Other comprehensive income (loss)	48			48
Net loss	(25,735)				(25,735)
Ending balance (in shares) at Jun. 30, 2023		149,845,546
Ending balance at Jun. 30, 2023	333,121	$ 1	1,015,851	(48)	(682,683)
Beginning balance (in shares) at Dec. 31, 2023		157,166,360
Beginning balance at Dec. 31, 2023	356,892	$ 2	1,076,508	80	(719,698)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	51,633		51,633
Exercise of stock options (in shares)		2,146,724
Exercise of stock options	377		377
Vesting of restricted stock units (in shares)		3,382,285
Vesting of restricted stock units	113		113
Issuance of common stock under employee stock purchase plan (in shares)		554,039
Issuance of common stock under employee stock purchase plan	4,533		4,533
Shares withheld related to net share settlement of equity awards (in shares)		(2,814,733)
Shares withheld related to net share settlement of equity awards	$ (19,905)		(19,905)
Repurchases of common stock (in shares)	(8,752,338)	(8,752,338)
Repurchases of common stock	$ (91,112)	$ 0	(91,112)
Other comprehensive income (loss)	(124)			(124)
Net loss	(50,153)				(50,153)
Ending balance (in shares) at Jun. 30, 2024		151,682,337
Ending balance at Jun. 30, 2024	252,254	$ 2	1,022,147	(44)	(769,851)
Beginning balance (in shares) at Mar. 31, 2024		153,591,721
Beginning balance at Mar. 31, 2024	296,494	$ 2	1,034,603	(74)	(738,037)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	26,567		26,567
Exercise of stock options (in shares)		1,365,726
Exercise of stock options	125		125
Vesting of restricted stock units (in shares)		1,633,696
Vesting of restricted stock units	113		113
Issuance of common stock under employee stock purchase plan (in shares)		554,039
Issuance of common stock under employee stock purchase plan	4,533		4,533
Shares withheld related to net share settlement of equity awards (in shares)		(1,672,652)
Shares withheld related to net share settlement of equity awards	$ (8,193)		(8,193)
Repurchases of common stock (in shares)	(3,790,193)	(3,790,193)
Repurchases of common stock	$ (35,601)	$ 0	(35,601)
Other comprehensive income (loss)	30			30
Net loss	(31,814)				(31,814)
Ending balance (in shares) at Jun. 30, 2024		151,682,337
Ending balance at Jun. 30, 2024	$ 252,254	$ 2	$ 1,022,147	$ (44)	$ (769,851)